Your fact-checks will appear here
Businessman and entrepreneur (born 1971)
Neuralink, Elon Musk’s brain‑computer interface company, has implanted at least three people and begun human trials aiming to restore motor function and eventually target diseases such as Alzheimer’s ...
Multiple news organizations and fact‑checkers dissected President Trump’s Dec. 17, 2025 televised address, focusing on economic and immigration claims; the checks repeatedly found his most specific nu...
Elon Musk is not behind a proven "cure" for dementia — viral claims about CBD gummies that "reverse dementia" are false and traced to fabricated stories , and while Musk's Neuralink is testing brain i...
Elon Musk’s Neuralink is an active neurotechnology company that has implanted brain–computer interface devices in humans and claims products like “Telepathy,” but independent experts and reporting not...
The viral claim that Elon Musk created a “dementia pill” or CBD gummies that “reverse dementia” is false and traced to fabricated articles and ad-driven scam pages . What is real is Musk’s involvement...
Available reporting in the provided search results shows no evidence that Elon Musk developed a treatment or device specifically for stress urinary incontinence. Most relevant items instead report all...
The supplied reporting consistently treats Elon Musk’s hair change as the result of surgical hair-restoration plus ongoing medical maintenance, not a $23 consumer “cure,” and experts and clinics estim...
The neuropathy product tied in viral ads to Elon Musk is called “Nerve Freedom,” a commercial supplement promoted in deceptive marketing that uses deepfaked Musk endorsements; reporting on these ads e...
The short answer is: False — there is no credible evidence that Elon Musk created or sells a “memory loss drug” or a product that reverses dementia; viral ads claiming Musk rolled out CBD gummies that...
Elon Musk has not announced a ready-made "dementia cure"; he and his company Neuralink have repeatedly said their brain‑computer interface aims to eventually help disorders including paralysis, Alzhei...
Available reporting links Elon Musk’s urinary problems to heavy ketamine use reported by the New York Times and summarized by multiple outlets; several pieces say chronic ketamine can cause “ketamine ...
There is no single product called “Elon Musk’s brain supplement”; public reporting shows Musk has discussed creatine and the importance of adequate vitamin B12 for cognitive performance, but he has no...
There is no evidence in the cited reporting that Elon Musk has “found a cure for incontinence.” Multiple news items discuss Musk’s reported heavy ketamine use and linked bladder problems — ketamine mi...
A widely circulated video purporting to show Elon Musk and Fox News host Laura Ingraham revealing a suppressed “brain health” or dementia cure appears to be a fabricated marketing asset used to promot...
“Trump Derangement Syndrome” or “TDS” is a pejorative, non‑clinical label used to describe intense, allegedly irrational negative reactions to Donald J. Trump; it is not a recognized psychiatric diagn...
Elon Musk has made public remarks linking his ventures—notably Neuralink—and personal statements about dementia (including preferring death to living with dementia) but there is no credible evidence i...
A Palm Beach County suit filed Nov. 24 seeks at least $310 million, accusing Donald Trump, Elon Musk and Bill Gates of operating an “Epstein‑identical” trafficking and exploitation venture and seeking...
There is no reliable reporting in the provided sources that Laura Ingraham ever interviewed Elon Musk specifically about bladder control or incontinence. Reporting in these results shows Ingraham has ...
Tesla has long teased a low-cost compact often called the “Model 2” with price targets ranging from roughly $25,000 to “under $30,000” depending on region and incentives; reporting shows plans have sh...
Available reporting identifies no “neuropathy medicine” that is owned by or specific to Elon Musk. Most coverage ties Musk to Neuralink, a company that develops implantable brain–computer interfaces, ...